CSPC Innovation Pharmaceutical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Feng Han
Chief executive officer
CN¥813.7k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.7yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 1.7yrs |
Recent management updates
Recent updates
Are CSPC Innovation Pharmaceutical Co., Ltd. (SZSE:300765) Investors Paying Above The Intrinsic Value?
Nov 21
Why CSPC Innovation Pharmaceutical's (SZSE:300765) Shaky Earnings Are Just The Beginning Of Its Problems
Oct 31Earnings Tell The Story For CSPC Innovation Pharmaceutical Co., Ltd. (SZSE:300765) As Its Stock Soars 27%
Sep 30Estimating The Fair Value Of CSPC Innovation Pharmaceutical Co., Ltd. (SZSE:300765)
Aug 16CSPC Innovation Pharmaceutical Co., Ltd.'s (SZSE:300765) 27% Share Price Plunge Could Signal Some Risk
Jul 04CSPC Innovation Pharmaceutical's (SZSE:300765) Weak Earnings May Only Reveal A Part Of The Whole Picture
Apr 29CSPC Innovation Pharmaceutical (SZSE:300765) Will Pay A Larger Dividend Than Last Year At CN¥0.32
Apr 25CSPC Innovation Pharmaceutical Co., Ltd.'s (SZSE:300765) P/E Still Appears To Be Reasonable
Apr 24CEO
Feng Han (50 yo)
1.7yrs
Tenure
CN¥813,700
Compensation
Mr. Feng Han is GM & Director of CSPC Innovation Pharmaceutical Co., Ltd. from April 07, 2023.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 1.7yrs | CN¥813.70k | no data | |
| Chairman | 7yrs | no data | no data | |
| Non-Independent Director | 7yrs | no data | 0.0013% CN¥ 472.2k | |
| Non-Independent Director | 1.7yrs | no data | no data | |
| Non-Independent Director | 1.7yrs | no data | no data | |
| Non-Independent Director | 1.7yrs | no data | no data | |
| Independent Director | 1.7yrs | CN¥45.00k | no data | |
| Independent Director | 1.7yrs | CN¥45.00k | no data | |
| Independent Director | 1.7yrs | CN¥45.00k | no data | |
| Non-Employee Supervisor | 1.7yrs | no data | no data | |
| Non-Employee Supervisor | 1.7yrs | no data | no data | |
| Employee Supervisor | 4.7yrs | no data | no data |
1.7yrs
Average Tenure
49.5yo
Average Age
Experienced Board: 300765's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 04:21 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
CSPC Innovation Pharmaceutical Co., Ltd. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shitong Han | Citic Securities Co., Ltd. |
| null null | CLSA |
| Zhijie Zhao | CLSA |